NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Buy
51
BMED Quote, Financials, Valuation and Earnings
Last price:
$24.98
Seasonality move
:
-1.76%
Day range:
$25.13 - $25.24
52-week range:
$23.99 - $26.68
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
319
Avg. volume:
736
1-year change:
6.55%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | -- | -- | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- |
|
LGHT
Langar Global HealthTech ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BMED
iShares Health Innovation Active ETF
|
$25.13 | -- | -- | -- | $0.01 | 0% | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
$14.74 | -- | -- | -- | $0.18 | 1.2% | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
$51.01 | -- | -- | -- | $2.49 | 4.88% | -- |
|
LGHT
Langar Global HealthTech ETF
|
$10.33 | -- | -- | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BMED
iShares Health Innovation Active ETF
|
-- | 1.308 | -- | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | 1.543 | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | 0.904 | -- | -- |
|
LGHT
Langar Global HealthTech ETF
|
-- | 0.000 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | -- | -- | -- | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- | -- |
|
LGHT
Langar Global HealthTech ETF
|
-- | -- | -- | -- | -- | -- |
iShares Health Innovation Active ETF vs. Competitors
-
Which has Higher Returns BMED or BMEZ?
BlackRock Health Sciences Trust II has a net margin of -- compared to iShares Health Innovation Active ETF's net margin of --. iShares Health Innovation Active ETF's return on equity of -- beat BlackRock Health Sciences Trust II's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEDiShares Health Innovation Active ETF-- -- -- BMEZBlackRock Health Sciences Trust II-- -- -- -
What do Analysts Say About BMED or BMEZ?
iShares Health Innovation Active ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand BlackRock Health Sciences Trust II has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Health Innovation Active ETF has higher upside potential than BlackRock Health Sciences Trust II, analysts believe iShares Health Innovation Active ETF is more attractive than BlackRock Health Sciences Trust II.
Company Buy Ratings Hold Ratings Sell Ratings BMEDiShares Health Innovation Active ETF0 0 0 BMEZBlackRock Health Sciences Trust II0 0 0 -
Is BMED or BMEZ More Risky?
iShares Health Innovation Active ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison BlackRock Health Sciences Trust II has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BMED or BMEZ?
iShares Health Innovation Active ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. BlackRock Health Sciences Trust II offers a yield of 1.2% to investors and pays a quarterly dividend of $0.18 per share. iShares Health Innovation Active ETF pays -- of its earnings as a dividend. BlackRock Health Sciences Trust II pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMED or BMEZ?
iShares Health Innovation Active ETF quarterly revenues are --, which are smaller than BlackRock Health Sciences Trust II quarterly revenues of --. iShares Health Innovation Active ETF's net income of -- is lower than BlackRock Health Sciences Trust II's net income of --. Notably, iShares Health Innovation Active ETF's price-to-earnings ratio is -- while BlackRock Health Sciences Trust II's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Health Innovation Active ETF is -- versus -- for BlackRock Health Sciences Trust II. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEDiShares Health Innovation Active ETF-- -- -- -- BMEZBlackRock Health Sciences Trust II-- -- -- --
-
Which has Higher Returns BMED or JDOC?
JPMorgan Healthcare Leaders ETF has a net margin of -- compared to iShares Health Innovation Active ETF's net margin of --. iShares Health Innovation Active ETF's return on equity of -- beat JPMorgan Healthcare Leaders ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEDiShares Health Innovation Active ETF-- -- -- JDOCJPMorgan Healthcare Leaders ETF-- -- -- -
What do Analysts Say About BMED or JDOC?
iShares Health Innovation Active ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand JPMorgan Healthcare Leaders ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Health Innovation Active ETF has higher upside potential than JPMorgan Healthcare Leaders ETF, analysts believe iShares Health Innovation Active ETF is more attractive than JPMorgan Healthcare Leaders ETF.
Company Buy Ratings Hold Ratings Sell Ratings BMEDiShares Health Innovation Active ETF0 0 0 JDOCJPMorgan Healthcare Leaders ETF0 0 0 -
Is BMED or JDOC More Risky?
iShares Health Innovation Active ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison JPMorgan Healthcare Leaders ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BMED or JDOC?
iShares Health Innovation Active ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. JPMorgan Healthcare Leaders ETF offers a yield of 4.88% to investors and pays a quarterly dividend of $2.49 per share. iShares Health Innovation Active ETF pays -- of its earnings as a dividend. JPMorgan Healthcare Leaders ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMED or JDOC?
iShares Health Innovation Active ETF quarterly revenues are --, which are smaller than JPMorgan Healthcare Leaders ETF quarterly revenues of --. iShares Health Innovation Active ETF's net income of -- is lower than JPMorgan Healthcare Leaders ETF's net income of --. Notably, iShares Health Innovation Active ETF's price-to-earnings ratio is -- while JPMorgan Healthcare Leaders ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Health Innovation Active ETF is -- versus -- for JPMorgan Healthcare Leaders ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEDiShares Health Innovation Active ETF-- -- -- -- JDOCJPMorgan Healthcare Leaders ETF-- -- -- --
-
Which has Higher Returns BMED or LGHT?
Langar Global HealthTech ETF has a net margin of -- compared to iShares Health Innovation Active ETF's net margin of --. iShares Health Innovation Active ETF's return on equity of -- beat Langar Global HealthTech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEDiShares Health Innovation Active ETF-- -- -- LGHTLangar Global HealthTech ETF-- -- -- -
What do Analysts Say About BMED or LGHT?
iShares Health Innovation Active ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Langar Global HealthTech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Health Innovation Active ETF has higher upside potential than Langar Global HealthTech ETF, analysts believe iShares Health Innovation Active ETF is more attractive than Langar Global HealthTech ETF.
Company Buy Ratings Hold Ratings Sell Ratings BMEDiShares Health Innovation Active ETF0 0 0 LGHTLangar Global HealthTech ETF0 0 0 -
Is BMED or LGHT More Risky?
iShares Health Innovation Active ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Langar Global HealthTech ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BMED or LGHT?
iShares Health Innovation Active ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Langar Global HealthTech ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iShares Health Innovation Active ETF pays -- of its earnings as a dividend. Langar Global HealthTech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMED or LGHT?
iShares Health Innovation Active ETF quarterly revenues are --, which are smaller than Langar Global HealthTech ETF quarterly revenues of --. iShares Health Innovation Active ETF's net income of -- is lower than Langar Global HealthTech ETF's net income of --. Notably, iShares Health Innovation Active ETF's price-to-earnings ratio is -- while Langar Global HealthTech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Health Innovation Active ETF is -- versus -- for Langar Global HealthTech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEDiShares Health Innovation Active ETF-- -- -- -- LGHTLangar Global HealthTech ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 3.25% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 8.13% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 4% over the past day.
